Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Capital Expenditures (2020 - 2024)

Terns Pharmaceuticals filings provide 5 years of Capital Expenditures readings, the most recent being $13000.0 for Q2 2024.

  • Quarterly Capital Expenditures changed N/A to $13000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $13000.0 through Mar 2025, down 83.95% year-over-year, with the annual reading at $42000.0 for FY2024, 19.23% down from the prior year.
  • Capital Expenditures hit $13000.0 in Q2 2024 for Terns Pharmaceuticals, down from $29000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $430000.0 in Q1 2020 and bottomed at -$8000.0 in Q3 2022.
  • Average Capital Expenditures over 5 years is $80812.5, with a median of $38000.0 recorded in 2021.
  • The largest annual shift saw Capital Expenditures surged 1380.0% in 2021 before it plummeted 110.81% in 2022.
  • Terns Pharmaceuticals' Capital Expenditures stood at $47000.0 in 2020, then soared by 325.53% to $200000.0 in 2021, then tumbled by 83.0% to $34000.0 in 2022, then increased by 29.41% to $44000.0 in 2023, then tumbled by 70.45% to $13000.0 in 2024.
  • Per Business Quant, the three most recent readings for TERN's Capital Expenditures are $13000.0 (Q2 2024), $29000.0 (Q1 2024), and $44000.0 (Q4 2023).